Prostatis Group’s Freeport-McMoran FCX Stock Holding History

Prostatis Group’s Portfolio FCX Stock Details FCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,592	Closed	-$229K	–	156
2024 Q3	$229K	Buy	+4,592	New	+$207K	0.08%	124

Other funds holding FCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Prostatis Group's FCX Position: Q4 2024 in Review

Prostatis Group sold out of Freeport-McMoran (FCX) in Q4 2024, closing a stake of 4,592 shares — an estimated $229K sold.

Prostatis Group first reported a position in FCX in Q3 2024 and held it in 1 quarter. The position peaked at $229K in Q3 2024. 1,476 funds tracked by Wall St. Rank hold FCX as of Q4 2024.

Prostatis Group reported no remaining Freeport-McMoran position as of Q4 2024 after selling out during the quarter.
Prostatis Group sold 4,592 Freeport-McMoran shares in Q4 2024, an estimated $229K.
Prostatis Group first reported a position in Freeport-McMoran in Q3 2024 and held it in 1 quarter.
Prostatis Group's Freeport-McMoran position peaked at $229K in Q3 2024.
1,476 funds tracked by Wall St. Rank held Freeport-McMoran as of Q4 2024.

Based on Prostatis Group's 13F filing for Q4 2024, filed 21 Mar 2025.